MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc

<< Previous

Bullboard Posts

Next >>

Post by Nathaniel13on Feb 10, 2021 9:07pm

196 Views

Post# 32533643

FDA Director of Diagnostics now talking antibody testing

The FDA’s lead man in diagnostics is now talking about antibody testing and “Diagnostic manufacturers are turning their attention to antibodies for those who have been vaccinated for the SARS-CoV-2 virus” seems like a clear sign that antibody testing is set to become an important market. Especially with him talking about the FDA working on guidelines for at-home antibody testing. Medmira has a head start and is one of the best in this area

https://www.bioworld.com/articles/503467-fdas-stenzel-think-of-antibody-tests-for-post-vaccination-as-a-companion-diagnostic

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver